Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease
- 1 May 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (84) , S117-S120
- https://doi.org/10.1046/j.1523-1755.63.s84.30.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Additive impacts of diabetes and renal failure on carotid atherosclerosisAtherosclerosis, 2000
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2Atherosclerosis, 1998
- Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and TherapyThe American Journal of Cardiology, 1998
- The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterolThe American Journal of Medicine, 1995
- High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremiaKidney International, 1995